These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30837324)

  • 1. Bioinformatics analysis of prognostic value of
    Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
    Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
    Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
    Wang Q; Zhao S; Gan L; Zhuang Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer.
    Chen YZ; Zuo D; Ren HL; Fan SJ; Ying G
    Technol Cancer Res Treat; 2019; 18():1533033819892260. PubMed ID: 31808361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
    Jing X; Liang H; Hao C; Yang X; Cui X
    Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.
    Hu Z; Huang G; Sadanandam A; Gu S; Lenburg ME; Pai M; Bayani N; Blakely EA; Gray JW; Mao JH
    Breast Cancer Res; 2010; 12(2):R18. PubMed ID: 20211017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of potential prognostic biomarkers among Krüppel-like transcription Factors (KLFs) in breast cancer.
    Cheng L; Shi L; Dai H
    Cancer Biomark; 2019; 26(4):411-420. PubMed ID: 31640084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
    Chen WQ; Yang SJ; Xu WX; Deng F; Wang DD; Tang JH
    Medicine (Baltimore); 2021 Oct; 100(42):e27489. PubMed ID: 34678879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
    Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
    Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
    Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
    BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the prognostic value of glutathione S-transferases Mu family members in breast cancer.
    Gohari N; Abbasi E; Akrami H
    Cell Biol Int; 2024 Sep; 48(9):1313-1325. PubMed ID: 38922769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of potential therapeutic targets among
    Chen WX; Lou M; Cheng L; Qian Q; Xu LY; Sun L; Zhu YL; Dai H
    Oncol Lett; 2019 Dec; 18(6):6017-6025. PubMed ID: 31788076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.